Artelo Biosciences Equity Warrant Exp 20 June 2024 ARTLW:NASDAQ

RT Quote | USD
Last | 05/14/24 EDT
0.0121UNCH (UNCH)
Volume
500
52 week range
0.00 - 0.21
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.0121
  • 52 Week High0.21
  • 52 Week High Date06/14/23
  • 52 Week Low0.00
  • 52 Week Low Date12/01/23

Key Stats

  • Market Cap-
  • Shares Out-
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.0121
  • 52 Week High0.21
  • 52 Week High Date06/14/23
  • 52 Week Low0.00
  • 52 Week Low Date12/01/23
  • Market Cap-
  • Shares Out-
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Artelo Biosciences Equity Warrant Exp 20 June 2024

 

Profile

MORE
Artelo Biosciences, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development of therapeutics that target lipid-signaling pathways, including the endocannabinoid system (ECS), a family of receptors and neurotransmitters that form a biochemical communication network throughout the body. It is developing a dual cannabinoid (CB) agonist that targets both the CB1 and CB2 receptors. This synthetic small molecule program is a G protein-coupled...
Connie Matsui
Independent Chairman of the Board
Gregory Gorgas
President, Chief Executive Officer, Chief Financial Officer, Treasurer, Company Secretary, Director
Address
505 LOMAS SANTA FE, SUITE 160
Solana Beach, CA
92075
United States